H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

<p> Dr. Iyad Alnahhas interviews Dr. Carl Koschmann about his and his team's recent manuscript entitled: "Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma" published online in Neuro-Oncology in February 2022.</p> <p> Read the Study</p>